NeueHealth, Inc. (NYSE:NEUE – Get Free Report) CAO Jeffrey J. Scherman sold 1,368 shares of the business’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $10,027.44. Following the sale, the chief accounting officer now directly owns 5,942 shares of the company’s stock, valued at $43,554.86. This represents a 18.71 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
NeueHealth Stock Up 0.7 %
NYSE:NEUE traded up $0.05 during midday trading on Wednesday, hitting $7.45. The stock had a trading volume of 38,124 shares, compared to its average volume of 70,685. The company has a market capitalization of $61.72 million, a price-to-earnings ratio of -0.15 and a beta of 0.57. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $16.59. The stock has a 50-day moving average of $5.47 and a 200 day moving average of $5.38.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the business. Deer Management Co. LLC purchased a new stake in shares of NeueHealth in the 2nd quarter worth approximately $5,436,000. NEA Management Company LLC bought a new position in NeueHealth in the second quarter worth approximately $14,834,000. Renaissance Technologies LLC purchased a new stake in NeueHealth during the second quarter worth $312,000. Finally, Partners Group Holding AG bought a new stake in NeueHealth during the 3rd quarter valued at $463,000. Hedge funds and other institutional investors own 63.88% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Research Report on NeueHealth
NeueHealth Company Profile
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
- Five stocks we like better than NeueHealth
- Stock Analyst Ratings and Canadian Analyst Ratings
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Retail Stocks Investing, Explained
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.